1. Home
  2. NKTX vs LFCR Comparison

NKTX vs LFCR Comparison

Compare NKTX & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nkarta Inc.

NKTX

Nkarta Inc.

N/A

Current Price

$2.95

Market Cap

198.2M

Sector

Health Care

ML Signal

N/A

Logo Lifecore Biomedical Inc.

LFCR

Lifecore Biomedical Inc.

N/A

Current Price

$4.16

Market Cap

190.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NKTX
LFCR
Founded
2015
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
198.2M
190.9M
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
NKTX
LFCR
Price
$2.95
$4.16
Analyst Decision
Strong Buy
Buy
Analyst Count
4
3
Target Price
$11.33
$6.00
AVG Volume (30 Days)
548.9K
123.7K
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
11.88
N/A
EPS
N/A
N/A
Revenue
N/A
$557,559,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$5.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
6.36
52 Week Low
$1.70
$3.63
52 Week High
$3.72
$8.98

Technical Indicators

Market Signals
Indicator
NKTX
LFCR
Relative Strength Index (RSI) 56.10 39.54
Support Level $2.59 $3.63
Resistance Level $3.29 $4.88
Average True Range (ATR) 0.19 0.21
MACD 0.01 -0.03
Stochastic Oscillator 39.13 17.50

Price Performance

Historical Comparison
NKTX
LFCR

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About LFCR Lifecore Biomedical Inc.

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.

Share on Social Networks: